These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 28358102

  • 21. Efficacy of siRNA nanocapsules targeted against the EWS-Fli1 oncogene in Ewing sarcoma.
    Toub N, Bertrand JR, Tamaddon A, Elhamess H, Hillaireau H, Maksimenko A, Maccario J, Malvy C, Fattal E, Couvreur P.
    Pharm Res; 2006 May; 23(5):892-900. PubMed ID: 16715379
    [Abstract] [Full Text] [Related]

  • 22. Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors.
    Erkizan HV, Scher LJ, Gamble SE, Barber-Rotenberg JS, Sajwan KP, Üren A, Toretsky JA.
    Cell Cycle; 2011 Oct 01; 10(19):3397-408. PubMed ID: 21926473
    [Abstract] [Full Text] [Related]

  • 23. RUNX3 facilitates growth of Ewing sarcoma cells.
    Bledsoe KL, McGee-Lawrence ME, Camilleri ET, Wang X, Riester SM, van Wijnen AJ, Oliveira AM, Westendorf JJ.
    J Cell Physiol; 2014 Dec 01; 229(12):2049-56. PubMed ID: 24812032
    [Abstract] [Full Text] [Related]

  • 24. Development of Mithramycin Analogues with Increased Selectivity toward ETS Transcription Factor Expressing Cancers.
    Mitra P, Eckenrode JM, Mandal A, Jha AK, Salem SM, Leggas M, Rohr J.
    J Med Chem; 2018 Sep 13; 61(17):8001-8016. PubMed ID: 30114371
    [Abstract] [Full Text] [Related]

  • 25. Impairment of p53 acetylation by EWS-Fli1 chimeric protein in Ewing family tumors.
    Li Y, Li X, Fan G, Fukushi J, Matsumoto Y, Iwamoto Y, Zhu Y.
    Cancer Lett; 2012 Jul 01; 320(1):14-22. PubMed ID: 22266186
    [Abstract] [Full Text] [Related]

  • 26. Ewing sarcoma EWS protein regulates midzone formation by recruiting Aurora B kinase to the midzone.
    Park H, Turkalo TK, Nelson K, Folmsbee SS, Robb C, Roper B, Azuma M.
    Cell Cycle; 2014 Jul 01; 13(15):2391-9. PubMed ID: 25483190
    [Abstract] [Full Text] [Related]

  • 27. Ewing's Sarcoma.
    Riggi N, Suvà ML, Stamenkovic I.
    N Engl J Med; 2021 Jan 14; 384(2):154-164. PubMed ID: 33497548
    [No Abstract] [Full Text] [Related]

  • 28. Genomic EWS-FLI1 fusion sequences in Ewing sarcoma resemble breakpoint characteristics of immature lymphoid malignancies.
    Berger M, Dirksen U, Braeuninger A, Koehler G, Juergens H, Krumbholz M, Metzler M.
    PLoS One; 2013 Jan 14; 8(2):e56408. PubMed ID: 23441188
    [Abstract] [Full Text] [Related]

  • 29. Ewing sarcoma: biology-based therapeutic perspectives.
    Potratz J, Jürgens H, Craft A, Dirksen U.
    Pediatr Hematol Oncol; 2012 Feb 14; 29(1):12-27. PubMed ID: 22304007
    [Abstract] [Full Text] [Related]

  • 30. Regulation of FAS exon definition and apoptosis by the Ewing sarcoma protein.
    Paronetto MP, Bernardis I, Volpe E, Bechara E, Sebestyén E, Eyras E, Valcárcel J.
    Cell Rep; 2014 May 22; 7(4):1211-26. PubMed ID: 24813895
    [Abstract] [Full Text] [Related]

  • 31. Linking germline and somatic variation in Ewing sarcoma.
    Gomez NC, Davis IJ.
    Nat Genet; 2015 Sep 22; 47(9):964-5. PubMed ID: 26313223
    [Abstract] [Full Text] [Related]

  • 32. Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing.
    Selvanathan SP, Graham GT, Erkizan HV, Dirksen U, Natarajan TG, Dakic A, Yu S, Liu X, Paulsen MT, Ljungman ME, Wu CH, Lawlor ER, Üren A, Toretsky JA.
    Proc Natl Acad Sci U S A; 2015 Mar 17; 112(11):E1307-16. PubMed ID: 25737553
    [Abstract] [Full Text] [Related]

  • 33. Epigenome mapping reveals distinct modes of gene regulation and widespread enhancer reprogramming by the oncogenic fusion protein EWS-FLI1.
    Tomazou EM, Sheffield NC, Schmidl C, Schuster M, Schönegger A, Datlinger P, Kubicek S, Bock C, Kovar H.
    Cell Rep; 2015 Feb 24; 10(7):1082-95. PubMed ID: 25704812
    [Abstract] [Full Text] [Related]

  • 34. EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma.
    Gorthi A, Romero JC, Loranc E, Cao L, Lawrence LA, Goodale E, Iniguez AB, Bernard X, Masamsetti VP, Roston S, Lawlor ER, Toretsky JA, Stegmaier K, Lessnick SL, Chen Y, Bishop AJR.
    Nature; 2018 Mar 15; 555(7696):387-391. PubMed ID: 29513652
    [Abstract] [Full Text] [Related]

  • 35. Molecular precision chemotherapy: overcoming resistance to targeted therapies?
    Burdach S.
    Clin Cancer Res; 2014 Mar 01; 20(5):1064-6. PubMed ID: 24536061
    [Abstract] [Full Text] [Related]

  • 36. Detection of EWS/FLI-1 fusion in non-Ewing soft tissue tumors.
    Trancău IO, Huică R, Surcel M, Munteanu A, Ursaciuc C.
    J Med Life; 2015 Mar 01; 8(1):85-9. PubMed ID: 25914746
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology Group.
    Monument MJ, Johnson KM, McIlvaine E, Abegglen L, Watkins WS, Jorde LB, Womer RB, Beeler N, Monovich L, Lawlor ER, Bridge JA, Schiffman JD, Krailo MD, Randall RL, Lessnick SL.
    PLoS One; 2014 Mar 01; 9(8):e104378. PubMed ID: 25093581
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Human EWS-FLI protein levels and neomorphic functions show a complex, function-specific dose-response relationship in Drosophila.
    Mahnoor S, Molnar C, Velázquez D, Reina J, Llamazares S, Heinen JP, Mora J, Gonzalez C.
    Open Biol; 2024 Jul 01; 14(7):240043. PubMed ID: 39013417
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.